News
If you had told me last year I could run a real business—one that hit six figures—without hiring a single employee, I’d have ...
Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity ...
did he fall out with trump? Tesla shows no sign of improvement in May sales data Sales are booming in Norway. Everywhere else, less so.
What Eden, a supply chain management major from Howell, Michigan, didn’t know was that he soon would be leading a process improvement project, collaborating with executive leadership at Goodwill and ...
Tesla shows no sign of improvement in May sales data JournalBot Jun 4, 2025 Jump to latest Follow Reply Jun 4, 2025 Replies: 320 ...
In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...
At the prespecified primary data analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival ...
The data used for training might include how you phrase your questions, the kind of topics you ask about, or any corrections you provide. By learning from millions of these exchanges, the AI ...
Learn more about the "The New Era of Healthcare Transformation: How Payers Can Leverage Data for Continuous Improvement" here.
CNN data guru Harry Enten marveled at how positively the American public still views the Republican Party, even after President Donald Trump launched his tariffs.
Johnson & Johnson reports long-term efficacy and steroid-sparing benefits of nipocalimab in antibody-positive generalized myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results